Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Genital Neoplasms, Female × Darbepoetin alfa × Clear all

Sponsor

Conditions

Anemia 5 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Leukemia 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms, Plasma Cell 2 Mycosis Fungoides 2 Multiple Myeloma 2 Monoclonal Gammopathy of Undetermined Significance 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Prolymphocytic 2 Leukemia, Mast-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Large Granular Lymphocytic 2 Leukemia, Hairy Cell 2 Leukemia, Biphenotypic, Acute 2 Immunoglobulin Light-chain Amyloidosis 2

Interventions

pembrolizumab 2 Pemetrexed 1 Palliative Care 1 Paclitaxel 1 Gemcitabine 1 Educational Status 1 Carboplatin 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡